Cargando…

Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial

BACKGROUND: Cognitive impairment is highly prevalent in COPD and is associated with a sedentary lifestyle, unhealthy diet and increased cognitive stress susceptibility. Enhancement of cognitive performance by working memory training (WMT) may reverse these effects. Therefore, this study aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: van Beers, Martijn, Mount, Sarah W., Houben, Katrijn, Gosker, Harry R., Schuurman, Lisanne, Franssen, Frits M.E., Janssen, Daisy J.A., Schols, Annemie M.W.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628195/
https://www.ncbi.nlm.nih.gov/pubmed/34853784
http://dx.doi.org/10.1183/23120541.00475-2021
_version_ 1784606968437014528
author van Beers, Martijn
Mount, Sarah W.
Houben, Katrijn
Gosker, Harry R.
Schuurman, Lisanne
Franssen, Frits M.E.
Janssen, Daisy J.A.
Schols, Annemie M.W.J.
author_facet van Beers, Martijn
Mount, Sarah W.
Houben, Katrijn
Gosker, Harry R.
Schuurman, Lisanne
Franssen, Frits M.E.
Janssen, Daisy J.A.
Schols, Annemie M.W.J.
author_sort van Beers, Martijn
collection PubMed
description BACKGROUND: Cognitive impairment is highly prevalent in COPD and is associated with a sedentary lifestyle, unhealthy diet and increased cognitive stress susceptibility. Enhancement of cognitive performance by working memory training (WMT) may reverse these effects. Therefore, this study aimed to investigate the efficacy of WMT in COPD on cognitive performance, healthy lifestyle behaviours and cognitive stress susceptibility. METHODS: The double-blind randomised, placebo-controlled Cogtrain trial consisted of a 12-week training phase comprising 30 active or sham WMT sessions, followed by a second 12-week maintenance phase with 12 sessions. Measurements took place at baseline and after the first and second phases. The primary outcome was cognitive performance. Secondary outcomes were the recall of prespecified healthy lifestyle goals, physical capacity and activity, dietary quality and cognitive stress susceptibility. Motivation towards exercising and healthy eating and psychological wellbeing were exploratory outcomes. RESULTS: Sixty-four patients with moderate COPD (45% male, aged 66.2±7.2 years, median forced expiratory volume in 1 s 60.6% predicted) were randomised. WMT significantly increased patients’ performance on the trained tasks in the first phase, which remained stable in the second phase. Of the 17 cognitive outcome measures, only one measure of memory improved after the first phase and one measure of reaction time after the second phase. This intervention did not influence physical capacity and activity, recall of prespecified healthy lifestyle goals, psychological wellbeing or cognitive stress susceptibility. CONCLUSION: WMT improved performance on the trained tasks but not overall cognitive performance, healthy lifestyle behaviours or cognitive stress susceptibility in patients with COPD.
format Online
Article
Text
id pubmed-8628195
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-86281952021-11-30 Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial van Beers, Martijn Mount, Sarah W. Houben, Katrijn Gosker, Harry R. Schuurman, Lisanne Franssen, Frits M.E. Janssen, Daisy J.A. Schols, Annemie M.W.J. ERJ Open Res Original Research Articles BACKGROUND: Cognitive impairment is highly prevalent in COPD and is associated with a sedentary lifestyle, unhealthy diet and increased cognitive stress susceptibility. Enhancement of cognitive performance by working memory training (WMT) may reverse these effects. Therefore, this study aimed to investigate the efficacy of WMT in COPD on cognitive performance, healthy lifestyle behaviours and cognitive stress susceptibility. METHODS: The double-blind randomised, placebo-controlled Cogtrain trial consisted of a 12-week training phase comprising 30 active or sham WMT sessions, followed by a second 12-week maintenance phase with 12 sessions. Measurements took place at baseline and after the first and second phases. The primary outcome was cognitive performance. Secondary outcomes were the recall of prespecified healthy lifestyle goals, physical capacity and activity, dietary quality and cognitive stress susceptibility. Motivation towards exercising and healthy eating and psychological wellbeing were exploratory outcomes. RESULTS: Sixty-four patients with moderate COPD (45% male, aged 66.2±7.2 years, median forced expiratory volume in 1 s 60.6% predicted) were randomised. WMT significantly increased patients’ performance on the trained tasks in the first phase, which remained stable in the second phase. Of the 17 cognitive outcome measures, only one measure of memory improved after the first phase and one measure of reaction time after the second phase. This intervention did not influence physical capacity and activity, recall of prespecified healthy lifestyle goals, psychological wellbeing or cognitive stress susceptibility. CONCLUSION: WMT improved performance on the trained tasks but not overall cognitive performance, healthy lifestyle behaviours or cognitive stress susceptibility in patients with COPD. European Respiratory Society 2021-11-29 /pmc/articles/PMC8628195/ /pubmed/34853784 http://dx.doi.org/10.1183/23120541.00475-2021 Text en Copyright ©The authors 2021 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Original Research Articles
van Beers, Martijn
Mount, Sarah W.
Houben, Katrijn
Gosker, Harry R.
Schuurman, Lisanne
Franssen, Frits M.E.
Janssen, Daisy J.A.
Schols, Annemie M.W.J.
Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
title Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
title_full Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
title_fullStr Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
title_full_unstemmed Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
title_short Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
title_sort working memory training efficacy in copd: the randomised, double-blind, placebo-controlled cogtrain trial
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628195/
https://www.ncbi.nlm.nih.gov/pubmed/34853784
http://dx.doi.org/10.1183/23120541.00475-2021
work_keys_str_mv AT vanbeersmartijn workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial
AT mountsarahw workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial
AT houbenkatrijn workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial
AT goskerharryr workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial
AT schuurmanlisanne workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial
AT franssenfritsme workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial
AT janssendaisyja workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial
AT scholsannemiemwj workingmemorytrainingefficacyincopdtherandomiseddoubleblindplacebocontrolledcogtraintrial